Kyung Nam Pharm Co.,Ltd. (KOSDAQ:053950)
1,482.00
-11.00 (-0.74%)
At close: Nov 13, 2026
Kyung Nam Pharm Revenue
Kyung Nam Pharm had revenue of 17.81B KRW in the quarter ending June 30, 2026, with 10.68% growth. This brings the company's total for the last twelve months to 54.89B, down -12.34% year-over-year. In the year 2024, Kyung Nam Pharm had annual revenue of 60.79B with 2.51% growth. That makes Kyung Nam Pharm the 29,325th largest company in the world by revenue and 1,810th in South Korea.
Revenue (ttm)
54.89B
Revenue Growth
-12.34%
P/S Ratio
0.53
Revenue / Employee
225.89M
Employees
243
Market Cap
29.08B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 60.79B | 1.49B | 2.51% |
| Dec 31, 2023 | 59.30B | 303.06M | 0.51% |
| Dec 31, 2022 | 59.00B | -5.62B | -8.70% |
| Dec 31, 2021 | 64.62B | -6.31B | -8.89% |
| Dec 31, 2020 | 70.93B | 26.13B | 58.31% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2010 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2009 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Korea Arlico Pharm | 195.70B |
| RP Bio | 141.42B |
| Korean Drug | 65.39B |
| Seoul Pharma | 51.08B |
| Eagle Veterinary Technology Co.,Ltd | 44.73B |
| Union Korea Pharm | 25.45B |
| Daesung Microbiological Labs. | 25.20B |
| Pharmsville | 11.20B |